Imipenem + Cilastatin - NDC Database
10 records found
Page:
0006-3514 Nov 26, 1985
Primaxin Intravenous Injection, Powder, for Solution by Merck Sharp & Dohme Corp.
Primaxin Intravenous Injection, Powder, for Solution by Merck Sharp & Dohme Corp.
0006-3516 Nov 26, 1985
Primaxin Intravenous Injection, Powder, for Solution by Merck Sharp & Dohme Corp.
Primaxin Intravenous Injection, Powder, for Solution by Merck Sharp & Dohme Corp.
0006-3551 Jan 08, 1987
Primaxin Intravenous Injection, Powder, for Solution by Merck Sharp & Dohme Corp.
Primaxin Intravenous Injection, Powder, for Solution by Merck Sharp & Dohme Corp.
0006-3552 Jan 08, 1987
Primaxin Intravenous Injection, Powder, for Solution by Merck Sharp & Dohme Corp.
Primaxin Intravenous Injection, Powder, for Solution by Merck Sharp & Dohme Corp.
0409-3507 Nov 17, 2011
Imipenem and Cilastatin Intravenous Injection, Powder, for Solution by Hospira, Inc.
Imipenem and Cilastatin Intravenous Injection, Powder, for Solution by Hospira, Inc.
0409-3508 Nov 17, 2011
Imipenem and Cilastatin Intravenous Injection, Powder, for Solution by Hospira, Inc.
Imipenem and Cilastatin Intravenous Injection, Powder, for Solution by Hospira, Inc.
44567-705 Mar 09, 2021
Imipenem and Cilastatin Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
Imipenem and Cilastatin Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
63323-322 Jan 03, 2012
Imipenem and Cilastatin Intravenous Injection, Powder, for Solution by App Pharmaceuticals, LLC
Imipenem and Cilastatin Intravenous Injection, Powder, for Solution by App Pharmaceuticals, LLC
63323-349 Jan 03, 2012
Imipenem and Cilastatin Intravenous Injection, Powder, for Solution by App Pharmaceuticals, LLC
Imipenem and Cilastatin Intravenous Injection, Powder, for Solution by App Pharmaceuticals, LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.